BIOPOR — BioPorto A/S Income Statement
0.000.00%
Last trade - 00:00
- DKK485.96m
- DKK426.81m
- DKK30.96m
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 26.6 | 23.2 | 24.3 | 29 | 31 |
Cost of Revenue | |||||
Gross Profit | 17.3 | 13.3 | 15 | 19 | 20.2 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 101 | 86.8 | 89.5 | 110 | 92.1 |
Operating Profit | -74.3 | -63.6 | -65.3 | -81.5 | -61.2 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -74.2 | -66.8 | -63.8 | -81.5 | -61.2 |
Provision for Income Taxes | |||||
Net Income After Taxes | -69.6 | -61.6 | -57.1 | -75.9 | -56.3 |
Net Income Before Extraordinary Items | |||||
Net Income | -69.6 | -61.6 | -57.1 | -75.9 | -56.3 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -69.6 | -61.6 | -57.1 | -75.9 | -56.3 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -1.3 | -0.288 | -0.205 | -0.224 | -0.155 |
Dividends per Share |